Insider Transactions Reported by 20 Insiders of HOOKIPA Pharma Inc.

Symbol
HOOK on OTC
Location
New York, NY

Insiders trading volume in the past year

HOOKIPA Pharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GILEAD SCIENCES, INC. 10%+ Owner $13,600,612 20 Dec 2023
Jorn Aldag Chief Executive Officer, Director $52,165 15 Apr 2024
Mary Theresa Coelho EVP and CFO, Director $51,764 -$12,520 -19% 22 Jul 2025
Malte Peters Chief Executive Officer, Director $44,656 -$47,526 -52% 19 Aug 2025
Reinhard Kandera Chief Financial Officer, Director $31,242 15 Apr 2024
Katia Schlienger Chief Medical Officer $943 14 Apr 2023
David Ross Kaufman Director 17 Jun 2024
Jean-Charles Soria Director 01 Jun 2021
Igor Matushansky Chief Medical Officer 30 Jun 2022
Christine D. Baker Chief Operating Officer 14 Apr 2023
Graziano Seghezzi Director 01 Jun 2021
Michael Aaron Kelly Director 30 Jun 2022
Julie O'Neill Director 17 Jun 2024
Jan van de Winkel Director 17 Jun 2024
Christoph Lengauer Director 01 Jun 2021
Sean A. Cassidy Director 22 Jul 2024
Mark Winderlich Chief Development Officer 15 Apr 2024
Timothy P. Reilly Director 17 Jun 2024
Roman Necina Chief Operations Officer 15 Apr 2024
Klaus Orlinger Chief Scientific Officer 15 Apr 2024

Recent Insider Transactions by Companies or Individuals for HOOKIPA Pharma Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Malte Peters HOOK Common Stock Sale -31.7% $20,684 $0.8217 -25,172 54,347 19 Aug 2025 Direct
Malte Peters HOOK Common Stock Sale -26.8% $26,842 $0.9200 -29,176 79,519 22 Jul 2025 Direct
Mary Theresa Coelho HOOK Common Stock Sale -19.5% $12,520 $0.9200 -13,609 56,266 22 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.